These results suggest that reduced surface c-KIT levels in CML LT-HSCs are not related to reduced RNA expression or protein relocalization to the intracellular compartment but could reflect increased c-KIT protein degradation, as was reported for normal c-KITlo LT-HSCs (21). Here, KIT is linked to chronic myelogenous leukemia, BCR-ABL1 positive.